Newsroom

Newsroom

NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier

Press Release
Read More

NeoGenomics Announces Proposed Public Offering of Common Stock

Press Release
Read More

NeoGenomics Announces Pricing on Public Offering of Common Stock

Press Release
Read More

NeoGenomics Announces Proposed Public Offering of Common Stock

Press Release
Read More

NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog

Press Release
Read More

NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018

Press Release
Read More

NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock

Press Release
Read More

Association between microsatellite instability and BRAF, TP53, PTEN, and KRAS mutations in colorectal cancer

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients